Oct 23, 2025 08:30AM Intelligent Bio Solutions secures UK contract with industrial service provider

Aug 25, 2025 05:03PM Intelligent Bio Solutions (INBS) Files $100M Mixed Shelf

Jul 30, 2025 08:30AM Intelligent Bio Solutions wins London transport drug testing contract

Jul 25, 2025 08:30AM Intelligent Bio Solutions raises $3.8 million through warrant exercise agreement

Jul 23, 2025 08:33AM Intelligent Bio Solutions collects data to strengthen FDA submission

Jul 16, 2025 08:32AM Intelligent Bio Solutions signs global distribution deal for SmarTest Patch

Jul 15, 2025 08:32AM Intelligent Bio Solutions adds wearable drug detection patch to portfolio

Jun 25, 2025 08:34AM Intelligent Bio Solutions (INBS) and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

Jun 11, 2025 08:31AM Intelligent Bio Solutions (INBS) Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

May 13, 2025 04:07PM Intelligent Bio Solutions (INBS) Misses Q3 EPS by 44c

Mar 26, 2025 08:31AM Intelligent Bio Solutions (INBS) Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

Mar 25, 2025 09:03AM Intelligent Bio Solutions' (INBS) FDA Clearance Process Remains on Track for 2025 U.S. Launch

Mar 20, 2025 08:32AM Intelligent Bio Solutions (INBS) to Expand U.S. IP Portfolio with Expected Patent Grant

Feb 20, 2025 08:31AM Intelligent Bio Solutions (INBS) Prices 1.3M Share Offering at $2/sh

Feb 19, 2025 04:42PM Intelligent Bio Solutions (INBS) Announces Proposed Public Offering of Common Stock

Feb 13, 2025 04:13PM Intelligent Bio Solutions (INBS) Misses Q2 EPS by 50c

Feb 7, 2025 08:33AM Intelligent Bio Solutions (INBS) Expands with UK Partnership

Jan 31, 2025 09:00AM Intelligent Bio Solutions (INBS) Expands Global Reach with Multilingual Drug Screening System Upgrade

Jan 29, 2025 09:10AM Intelligent Bio Solutions (INBS) Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing

Dec 18, 2024 08:31AM Intelligent Bio Solutions (INBS) Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology

Nov 26, 2024 08:31AM Intelligent Bio Solutions (INBS) Achieves 94.1% Accuracy in Method Comparison Study

Nov 13, 2024 08:35AM Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission

Oct 31, 2024 08:34AM Intelligent Bio Solutions (INBS) Partners with B2i Digital to Amplify Investor Outreach

Oct 29, 2024 08:31AM Intelligent Bio Solutions (INBS) Reports Prelim Q1 Results

Oct 16, 2024 08:00AM Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles

Oct 14, 2024 08:00AM Intelligent Bio Solutions (INBS) Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek

Sep 27, 2024 08:32AM Intelligent Bio Solutions (INBS) Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission

Aug 21, 2024 08:31AM Intelligent Bio Solutions (INBS) Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024

Jul 18, 2024 08:37AM Intelligent Bio Solutions (INBS) Advances on FDA 510(k) Pathway with Biocompatibility Study Success

Jun 27, 2024 08:36AM Intelligent Bio Solutions (INBS) Expands Presence in the UK Retail Sector with Major Account Acquisitions

Jun 12, 2024 08:32AM Intelligent Bio Solutions (INBS) Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology